These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9119883)

  • 1. Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trail.
    Wamil BD; Thurman GB; Sundell HW; DeVore RF; Wakefield G; Johnson DH; Wang YF; Hellerqvist CG
    J Cancer Res Clin Oncol; 1997; 123(3):173-9. PubMed ID: 9119883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of the antineovascularization drug CM101.
    DeVore RF; Hellerqvist CG; Wakefield GB; Wamil BD; Thurman GB; Minton PA; Sundell HW; Yan HP; Carter CE; Wang YF; York GE; Zhang MH; Johnson DH
    Clin Cancer Res; 1997 Mar; 3(3):365-72. PubMed ID: 9815693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis.
    Yakes FM; Wamil BD; Sun F; Yan HP; Carter CE; Hellerqvist CG
    Cancer Res; 2000 Oct; 60(20):5740-6. PubMed ID: 11059768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional studies on the anti-pathoangiogenic properties of CM101.
    Yan HP; Carter CE; Wang EZ; Page DL; Washington K; Wamil BD; Yakes FM; Thurman GB; Hellerqvist CG
    Angiogenesis; 1998; 2(3):219-33. PubMed ID: 14517462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and identification of the group B streptococcal toxin CM101 from infants with sepsis.
    Sundell HW; Yan H; Carter CE; Wamil BD; Wu K; Gaddipati R; Li D; Hellerqvist CG
    J Pediatr; 2000 Sep; 137(3):338-44. PubMed ID: 10969257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis.
    Byrne GJ; Ghellal A; Iddon J; Blann AD; Venizelos V; Kumar S; Howell A; Bundred NJ
    J Natl Cancer Inst; 2000 Aug; 92(16):1329-36. PubMed ID: 10944555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CM101, a polysaccharide antitumor agent, does not inhibit wound healing in murine models.
    Quinn TE; Thurman GB; Sundell AK; Zhang M; Hellerqvist CG
    J Cancer Res Clin Oncol; 1995; 121(4):253-6. PubMed ID: 7538506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.
    Hebbar M; Révillion F; Louchez MM; Vilain MO; Fournier C; Bonneterre J; Peyrat JP
    Clin Cancer Res; 1998 Feb; 4(2):373-80. PubMed ID: 9516925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
    Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
    Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of soluble endothelial molecule E-selectin in patients with breast cancer.
    Hebbar M; Peyrat JP
    Int J Biol Markers; 2000; 15(1):15-21. PubMed ID: 10763135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of soluble E-selectin are associated with the clinical course of metastatic disease in patients with liver metastases from breast cancer.
    Eichbaum MH; de Rossi TM; Kaul S; Bastert G
    Oncol Res; 2004; 14(11-12):603-10. PubMed ID: 15667001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of E-selectin in tissue and its protein level in serum of breast cancer patients.
    Shaker OG; Ay El-Deen MA; Abd El-Rahim MT; Talaat RM
    Tumori; 2006; 92(6):524-30. PubMed ID: 17260494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct accumulation patterns of soluble forms of E-selectin, VCAM-1 and ICAM-1 upon infusion of TNFalpha in tumor patients.
    Lieuw-a-Fa M; Schalkwijk C; van Hinsbergh VW
    Thromb Haemost; 2003 Jun; 89(6):1052-7. PubMed ID: 12783118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased concentration of soluble E-selectin in the sera of breast cancer patients.
    Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
    Anticancer Res; 1997; 17(2B):1367-72. PubMed ID: 9137500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble E-selectin levels in sepsis and critical illness. Correlation with infection and hemodynamic dysfunction.
    Cummings CJ; Sessler CN; Beall LD; Fisher BJ; Best AM; Fowler AA
    Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):431-7. PubMed ID: 9279220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation of soluble E-selectin level with renal transplant rejection.
    Weston SD; Lycett AE; Edwards C; Morgan JD; Horsburgh T; Veitch PS; Bell PR
    Transpl Immunol; 1995 Mar; 3(1):50-4. PubMed ID: 7551979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.
    Gregorc V; Citterio G; Vitali G; Spreafico A; Scifo P; Borri A; Donadoni G; Rossoni G; Corti A; Caligaris-Cappio F; Del Maschio A; Esposito A; De Cobelli F; Dell'Acqua F; Troysi A; Bruzzi P; Lambiase A; Bordignon C
    Eur J Cancer; 2010 Jan; 46(1):198-206. PubMed ID: 19900802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.